Merck today announced a collaborative partnership with Siemens for the digitalization of production.  DARMSTADT, GERMANY Collaboration is to advance modular production in industry In the future, it will be possible to meet customer and market requirements quicker, more efficiently and more flexibly Merck invests € 10 million in modular technical infrastructure Merck, a leading science […]

SAN DIEGO — Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced the closing of its initial public offering of 69,000,000 shares of Class A common stock, including the full exercise of the underwriters’ option to purchase up to 9,000,000 additional shares of […]

Early access service available now; standalone instrument launching early 2021 Rebus Biosystems is the new name for Optical Biosystems SANTA CLARA, Calif. — Rebus Biosystems, Inc., a life science technology company building innovative tools to enable spatial omics without compromise, today announced the closing of a $20 million Series B financing round, led by Illumina Ventures and joined by Lifecore Partners, Ncore Ventures, Xolon Invest, CTK Investments, Ray Co., Ltd., Seegene Medical Foundation, LabGenomics Co., Ltd., and Timefolio Asset Management.  […]

Photo by National Cancer Institute on Unsplash shows human colorectal cancer cells treated with an inhibitor under study as a cancer therapy. Created by Yves Pommier, Rozenn Josse. Griffith University will establish a Centre of Excellence (CoE) in spatial biology in collaboration with Nanostring Technologies, a publicly held provider of life science tools for translational research […]

Sydney, Australia – Bioprinting holds enormous promise in medicine in areas such as tissue engineering, regenerative medicine and drug discovery. AXT has identified the potential for this technology to print tissues and even organs and has partnered with REGENHU to offer their unique bioprinters to Australian and New Zealand researchers. REGENHU is a research driven Swiss […]

SaudiVax intends to increase access to vaccines to 20 times more people in the Middle East and Africa than today First bioprocessing facility for halal vaccines in-region, for region Remote Factory Acceptance Testing (FAT) helped avoid COVID-19 related delays   Cytiva, a global life sciences leader, is installing its first FlexFactory in the Middle East […]

High-throughput screening for applications in virology, immunotherapy, oncology, receptor-signaling, and more Axion BioSystems has launched the Maestro ZHT high-throughput screening platform, leveraging their expertise in live-cell instrumentation to add a new dimension to drug discovery and development. Rapid technological advances are leading to a host of new drug, biologic, and cell-based therapeutics, creating new medical treatments thought […]

Clover aims to double its commercial manufacturing capacity in preparation for global Phase 2/3 trials Cytiva provides FlexFactoryTM bioprocessing upstream and downstream solutions for Clover to accelerate GMP facility development and shorten time to market Cytiva, a global life sciences leader, is supporting Clover Biopharmaceuticals, a global clinical-stage biotechnology company, to help accelerate the development […]

FUJIFILM Cellular Dynamics grants Lonza a non-exclusive right to use their patents related to iPSC generation, including episomal vectors and reprogramming factors, for development and clinical manufacture of iPSC lines for cell therapies  Lonza grants FUJIFILM Cellular Dynamics expanded use of its non-exclusive license to its innovative NucleofectorTM technology The agreement enables drug developers to […]

Indianapolis, Indiana  – Beckman Coulter Life Sciences signed a definitive agreement to acquire m2p-labs, a privately held, microbioreactor manufacturer based in Baesweiler, Germany. m2p-labs is best known for its transformative BioLector plate-based microbioreactors, which support automated solutions for screening and bioprocess development. “Innovation defines our future,” said Greg Milosevich, President, Beckman Coulter Life Sciences. “m2p-labs […]